Preclinical Formulation Development – Our team can expertly develop a variety of formulations—ranging from simple to complex—including formulations for parenteral, oral, dermal, ocular and inhaled dosing in preclinical studies. The desired route of dose administration will consider the target site, bioavailability/disposition, and pharmacokinetics of the therapeutic entity. Dose formulations can be analyzed for content, stability, purity, pH and homogeneity.


  • Respiratory formulation (nebulizer, metered dose inhaler, dry powders)
  • Parenteral formulation
  • Oral formulation
  • Dermal formulation